Denali Therapeutics Inc. (DNLI) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Denali Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -5.65x | -7.93x | -20.30x | -10.71x | -18.65x | 128.31x |
| P/B Ratio | 2.86x | 2.73x | 2.86x | 3.35x | 5.63x | 7.93x |
| P/S Ratio | 0.00x | 0.00x | 8.92x | 32.19x | 111.38x | 27.19x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 0.0% | 0.0% | -59.5% | -314.2% | -607.8% | 18.7% |
| Net Margin | 0.0% | 0.0% | -43.9% | -300.6% | -597.2% | 21.2% |
| EBITDA Margin | 0.0% | 0.0% | -54.4% | -304.6% | -590.1% | 21.2% |
| Liquidity | ||||||
| Current Ratio | 9.16x | 8.46x | 13.65x | 3.77x | 2.37x | 20.86x |
| Quick Ratio | 9.16x | 8.46x | 13.65x | 3.77x | 2.37x | 20.86x |
| Leverage | ||||||
| Debt/Equity | 0.04x | 0.04x | 0.05x | 0.06x | 0.07x | 0.06x |
YoY = year-over-year change. Source: FMP..